Jul 20, 2026 08:30AM
Jul 20, 2026 08:30AM
Jun 30, 2026 08:45AM
Jun 30, 2026 08:45AM
May 18, 2026 08:45AM
May 18, 2026 08:45AM
May 14, 2026 08:30AM Dogwood Therapeutics Announces First Quarter 2026 Financial Results
May 7, 2026 08:30AM
Apr 23, 2026 09:00AM
Apr 23, 2026 09:00AM
Apr 15, 2026 09:02AM
Apr 15, 2026 09:00AM
Mar 18, 2026 08:30AM
Feb 2, 2026 08:30AM Dogwood Therapeutics Announces 50% Enrollment in Ongoing Halneuron® Phase 2b Trial, Top Line Results Anticipated in Q3 2026
Jan 20, 2026 08:38AM
Jan 12, 2026 08:33AM
Jan 12, 2026 08:30AM
Dec 22, 2025 10:15AM
Dec 22, 2025 10:15AM
Dec 2, 2025 08:06AM
Dec 2, 2025 08:00AM Dogwood Therapeutics Files New Synthetic Halneuron(R) Intellectual Property Protection Projected to Extend Exclusivity Period Up to 2045
Nov 11, 2025 08:45AM
Nov 6, 2025 08:45AM
Oct 30, 2025 09:15AM
Sep 29, 2025 07:19AM
Sep 29, 2025 07:15AM
Sep 3, 2025 09:15AM
Aug 13, 2025 09:00AM Dogwood Therapeutics Reports Second Quarter 2025 Financial Results
Aug 7, 2025 01:10PM
Aug 7, 2025 01:08PM
Aug 6, 2025 09:15AM
Jun 3, 2025 09:15AM
May 8, 2025 09:00AM
May 1, 2025 08:30AM
Apr 23, 2025 06:35AM H.C. Wainwright Upgrades Dogwood Therapeutics, Inc. (DWTX) to Buy
Apr 11, 2025 09:15AM
Apr 11, 2025 09:15AM
Apr 3, 2025 09:00AM
Apr 3, 2025 09:00AM
Mar 31, 2025 03:45PM
Mar 18, 2025 08:45AM
Mar 18, 2025 08:45AM Dogwood Therapeutics Announces Dosing of First Patient in Phase 2b Trial Evaluating Halneuron® in Patients with Chemotherapy-Induced Neuropathic Pain
Mar 13, 2025 09:02AM
Mar 13, 2025 09:00AM
Mar 12, 2025 08:31AM
Mar 12, 2025 08:30AM
Jan 21, 2025 09:15AM
Nov 18, 2024 08:46AM
Nov 18, 2024 08:45AM Dogwood Therapeutics, Inc. Announces Low Dose IMC-2 Treatment Reduces Long-COVID Related Fatigue and Sleep Disturbance in an Investigator-Initiated Study
Nov 7, 2024 07:05AM

326,714 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All